# Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

> **NCT01639807** · NA · UNKNOWN · sponsor: **Aurolab** · enrollment: 600 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Latanoprost
- **PROCEDURE:** SLT

## Key facts

- **NCT ID:** NCT01639807
- **Lead sponsor:** Aurolab
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-10
- **Primary completion:** 2013-10
- **Final completion:** 2014-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2012-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639807, "Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01639807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
